Rubescensine A having antitumor activity and fluorine-containing derivatives of 6,7-cyclobebescensine A, preparation method and use

A technology of Rubescensine A and medicinal salts, applied in the fields of natural medicine and medicinal chemistry, and can solve the problems of limited application, poor water solubility and the like

Inactive Publication Date: 2011-12-28
CHINA PHARM UNIV
View PDF4 Cites 35 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Oridonin and other diterpenoids have poor water solubility, which limits the clinical application of these drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rubescensine A having antitumor activity and fluorine-containing derivatives of 6,7-cyclobebescensine A, preparation method and use
  • Rubescensine A having antitumor activity and fluorine-containing derivatives of 6,7-cyclobebescensine A, preparation method and use
  • Rubescensine A having antitumor activity and fluorine-containing derivatives of 6,7-cyclobebescensine A, preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0122] ent-1α-hydroxy-6β,7β-dihydroxy-[14β-O-(4-trifluoromethylbenzoyl)]-15-oxo-7,20-oxo-16-kaurene

[0123] Dissolve oridonin (72mg, 0.2mmol) in 15ml of dichloromethane, add 4-trifluoromethylbenzoic acid (57mg, 0.3mmol), stir at room temperature for 12 hours, add appropriate amount of water (about 15ml), acetic acid Extracted with ethyl ester (10ml×3 times), washed with saturated brine, dried over anhydrous sodium sulfate, filtered, concentrated, and column chromatography (dichloromethane:methanol=300:1) gave 58mg of white powdery solid (yield 54% ): m.p.270-275℃; 1 H-NMR (CDCl 3 , 300M Hz), δ (ppm): 1.11 (3H, s, 19-CH 3 ), 1.13 (3H, s, 18-CH 3 ), 1.26 (1H, m, 5-CH), 1.46 (2H, m, 3-CH 2 ), 1.65 (2H, m, 2-CH 2 ), 1.83 (1H, m, 9-CH), 2.02 (2H, m, 11-CH 2 ), 2.33 (1H, m, 12-CH), 2.68 (1H, m, 12-CH 2 ), 3.27 (1H, d, J=9.6Hz, 13-CH), 3.54 (1H, m, 1-CH), 3.76 (1H, m, 6-CH), 3.78 (1H, s, 1-OH) , 4.09, 4.38 (each 1H, dd, J A =J B =10.2Hz, 20-CH 2 ), 5.54 (1H, s, 17-CH 2 )...

Embodiment 2

[0125] ent-1α-hydroxy-6β,7β-dihydroxy-[14β-O-(4-fluorobenzoyl)]-15-oxo-7,20-oxo-16-kaurene

[0126] Reference Example 1: ent-1α-hydroxy-6β, 7β-dihydroxy-[14β-O-(4-trifluoromethylbenzoyl)]-15-oxo-7,20-oxo-16- Synthetic method of kaurene. 58 mg of white solid was obtained (59% yield): m.p.90-93°C; 1 H-NMR (CDCl 3 , 500MHz), δ (ppm): 1.12 (3H, s, 19-CH 3 ), 1.13 (3H, s, 18-CH 3 ), 1.29 (1H, m, 5-CH), 1.48 (2H, m, 3-CH 2 ), 1.64 (2H, m, 2-CH 2 ), 1.80 (1H, m, 9-CH), 2.01 (2H, m, 11-CH 2 ), 2.34 (1H, m, 12-CH 2 ), 2.67 (1H, m, 12-CH 2 ), 3.28 (1H, d, J=9.5Hz, 13-CH), 3.52 (1H, m, 1-CH), 3.76 (1H, m, 6-CH), 3.90 (1H, s, 1-OH) , 4.09, 4.37 (each 1H, dd, J A =J B =10.0Hz, 20-CH 2 ), 5.51 (1H, s, 17-CH 2 ), 6.08 (1H, d, 6-OH), 6.11 (1H, s, 14-CH), 6.19 (1H, s, 17-CH 2 ), 7.06 (2H, m, Ar-H), 7.94 (2H, m, Ar-H). MS (ESI) m / z: 487.2 [M+H] + , 509.2[M+Na] + , 525.2[M+K] + .

Embodiment 3

[0128] ent-1α-hydroxy-6β,7β-dihydroxy-[14β-O-(3-fluorobenzoyl)]-15-oxo-7,20-oxo-16-kaurene

[0129] Reference Example 1: ent-1α-hydroxy-6β, 7β-dihydroxy-[14β-O-(4-trifluoromethylbenzoyl)]-15-oxo-7,20-oxo-16- Synthetic method of kaurene. 60 mg of white solid was obtained (61% yield): m.p.228-230°C; 1 H-NMR (CDCl 3 , 500M Hz), δ (ppm): 1.11 (3H, s, 19-CH 3 ), 1.13 (3H, s, 18-CH 3 ), 1.29 (1H, m, 5-CH), 1.46 (2H, m, 3-CH 2 ), 1.64 (2H, m, 2-CH 2 ), 1.81 (1H, m, 9-CH), 2.02 (1H, m, 11-CH 2 ), 2.33 (1H, m, 12-CH 2 ), 2.68 (1H, m, 12-CH 2 ), 3.28 (1H, d, J=10.0Hz, 13-CH), 3.53 (1H, m, 1-CH), 3.75 (1H, m, 6-CH), 3.87 (1H, s, 1-OH) , 4.10, 4.37 (each 1H, dd, J A =J B =10.0Hz, 20-CH 2 ), 5.53 (1H, s, 17-CH 2 ), 6.09 (1H, d, J=10.0Hz, 6-OH), 6.12 (1H, s, 14-CH), 6.21 (1H, s, 17-CH 2 ), 7.23 (1H, m, Ar-H), 7.37 (1H, m, Ar-H), 7.62 (1H, d, J=10.0Hz, Ar-H), 7.71 (1H, d, J=10.0Hz , Ar-H). MS (ESI) m / z: 487.2 [M+H] + , 509.2[M+Na] + , 525.2[M+K] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the fields of natural medicine and medicinal chemistry, in particular to a class of oridonin and ent-6,7-ring-opened kaurene-type oridonin fluorine-containing derivatives with antitumor activity. The invention also discloses the preparation method of these oridonin A and ent-6,7-opening ring oridonin A fluorine-containing derivatives, the pharmaceutical composition containing the compound and the use of the compound in the treatment of tumor diseases Applications.

Description

technical field [0001] The invention relates to the fields of natural medicine and medicinal chemistry, in particular to oridonin A and ent-6,7-opening-ring oridonin A fluorine-containing derivatives modified at the 14th position and the 1st and 14th positions simultaneously. The invention discloses the preparation method of these oridonin A and ent-6,7-opening ring oridonin A fluorine-containing derivatives and the application for preparing antitumor drugs. Background technique [0002] Oridonin is a natural organic compound of ent-kaurene diterpenoid isolated from the Lamiaceae Rabdosia plant. In 1967, E.Fujita, a professor at Kyoto University in Japan, extracted and isolated Oridonin A for the first time from Yanmeicao, and identified and analyzed its structure (see E.Fujita, T.Fujita, et al.Chem.Comm., 1967, 32:252). Oridonin was obtained for the first time in China in 1977, and its structure was identified (see the Pharmacology and Pharmacology Group of Henan Academy ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D493/08C07D493/10C07D311/96A61K31/352A61K31/366A61P35/00A61P35/02
Inventor 徐进宜李达翃蔡浩王磊徐盛涛孙飞姚和权蒋洁云孙益军
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap